Lipoprotein lipase greatly enhances the retention of lipoprotein(a) to endothelial cell-matrix.

[1]  M. Linton,et al.  Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Gupta,et al.  Correlation of lipoprotein (a) to angiographically defined coronary artery disease in Indians. , 1996, International journal of cardiology.

[3]  B. Nordestgaard,et al.  Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerotic compared with nonlesioned rabbit aorta. , 1996, The Journal of clinical investigation.

[4]  A. von Eckardstein,et al.  Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. , 1996, The American journal of cardiology.

[5]  K. Kario,et al.  'Silent' cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high Lp(a) levels in elderly Japanese. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[6]  J. Wölle,et al.  Oxidation of Low Density Lipoproteins Greatly Enhances Their Association with Lipoprotein Lipase Anchored to Endothelial Cell Matrix (*) , 1996, The Journal of Biological Chemistry.

[7]  A. Stead,et al.  Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease. , 1995, Stroke.

[8]  B. Nordestgaard,et al.  Transfer of lipoprotein(a) and LDL into aortic intima in normal and in cholesterol-fed rabbits. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[9]  G. Assmann,et al.  Dose-Response Relationships of Serum Lipid Measurements With the Extent of Coronary Stenosis , 1995 .

[10]  R. Hegele,et al.  Apolipoprotein B and E basic amino acid clusters influence low-density lipoprotein association with lipoprotein lipase anchored to the subendothelial matrix. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[11]  U. Beisiegel,et al.  Extraction of lipoprotein(a), apo B, and apo E from fresh human arterial wall and atherosclerotic plaques. , 1995, Atherosclerosis.

[12]  D. Rader,et al.  The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. , 1995, The Journal of clinical investigation.

[13]  C. Ayers,et al.  Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty. , 1995, Circulation.

[14]  M. Koschinsky,et al.  Binding of recombinant apolipoprotein(a) to extracellular matrix proteins. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[15]  S. Chierchia,et al.  Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age. , 1994, The American journal of cardiology.

[16]  M. Farrer,et al.  Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[17]  S. Jimi,et al.  Low density lipoproteins bind more to type I and III collagens by negative charge-dependent mechanisms than to type IV and V collagens. , 1994, Atherosclerosis.

[18]  S. Jimi,et al.  Oxidized Low Density Lipoproteins Bind to Collagen by Negative‐Charge‐Dependent Mechanisms , 1994, Annals of the New York Academy of Sciences.

[19]  C. Bisgaier,et al.  Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix. , 1993, The Journal of biological chemistry.

[20]  M. Ferguson,et al.  Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. , 1992, The Journal of clinical investigation.

[21]  M. Klein,et al.  Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix. , 1992, The Journal of clinical investigation.

[22]  D. Steinberg,et al.  Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  H. Hoff,et al.  Quantification of apo[a] and apoB in human atherosclerotic lesions. , 1991, Journal of lipid research.

[24]  G. Kostner,et al.  Interaction of lipoprotein Lp[a] with the B/E-receptor: a study using isolated bovine adrenal cortex and human fibroblast receptors. , 1990, Journal of lipid research.

[25]  V. Armstrong,et al.  Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor. , 1990, Journal of lipid research.

[26]  M. Dietel,et al.  Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. , 1989, Arteriosclerosis.

[27]  I. Goldberg,et al.  Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids. , 1989, The Journal of biological chemistry.

[28]  H. Eder,et al.  Isolation and lipid-binding properties of rat apolipoprotein A-IV. , 1985, Biochimica et biophysica acta.

[29]  A. Roscher,et al.  Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man. , 1983, The Journal of clinical investigation.

[30]  D. Bilheimer,et al.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. , 1972, Biochimica et biophysica acta.

[31]  A. Mcfarlane,et al.  Efficient Trace-labelling of Proteins with Iodine , 1958, Nature.

[32]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[33]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[34]  Z. Yiyi,et al.  Apolipoprotein(a) phenotypes in cardio-cerebrovascular diseases. , 1994 .

[35]  G. Smejkal,et al.  Immunochemically detectable lipid-free apo(a) in plasma and in human atherosclerotic lesions. , 1994, Chemistry and physics of lipids.

[36]  P. Schreiner,et al.  Lipoprotein(a) as a risk factor for preclinical atherosclerotic disease in a biracial cohort: the Atherosclerosis Risk in Communities (ARIC) Study. , 1994, Chemistry and physics of lipids.